| Debra O'day, | |
|
1323 W 6th Ave, Stillwater, OK 74074-4306 | |
| (405) 372-1480 | |
| Not Available |
| Full Name | Debra O'day |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 1323 W 6th Ave, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013392737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | 86131 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Central Emergency Services, Pc | 8224212949 | 47 |
News Archive
Breast cancer survivors like many other cancer survivors live in fear of relapse of their cancer after they have been in remission. Researchers have now developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of the journal Nature.
Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.
Seamless. Secure. Simple. Ask any company's Information Technology department what a healthy, reliable computer network looks like and it often boils down to those three words.
The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.
The U.S. Preventive Services Task Force has found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. The report appears in the June 7 issue of JAMA.
› Verified 4 days ago
| Entity Name | South Central Emergency Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558663724 PECOS PAC ID: 8224212949 Enrollment ID: O20110405000201 |
News Archive
Breast cancer survivors like many other cancer survivors live in fear of relapse of their cancer after they have been in remission. Researchers have now developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of the journal Nature.
Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.
Seamless. Secure. Simple. Ask any company's Information Technology department what a healthy, reliable computer network looks like and it often boils down to those three words.
The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.
The U.S. Preventive Services Task Force has found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. The report appears in the June 7 issue of JAMA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra O'day, 1323 W 6th Ave, Stillwater, OK 74074-4306 Ph: (405) 372-1480 | Debra O'day, 1323 W 6th Ave, Stillwater, OK 74074-4306 Ph: (405) 372-1480 |
News Archive
Breast cancer survivors like many other cancer survivors live in fear of relapse of their cancer after they have been in remission. Researchers have now developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of the journal Nature.
Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.
Seamless. Secure. Simple. Ask any company's Information Technology department what a healthy, reliable computer network looks like and it often boils down to those three words.
The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.
The U.S. Preventive Services Task Force has found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. The report appears in the June 7 issue of JAMA.
› Verified 4 days ago
Connie R Lowry, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1815 W 6th Ave, Stillwater, OK 74074 Phone: 405-743-7300 | |
Toby Lea Miller, APRN-CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1603 W 9th Ave, Stillwater, OK 74074 Phone: 405-379-0002 Fax: 405-300-1090 | |
Jeremiah Bro, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 6th Ave Ste 207, Stillwater, OK 74074 Phone: 405-533-3010 | |
Mrs. Laura De Mauriac Shaw, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1411 W 7th St, Ste 102, Stillwater, OK 74074 Phone: 405-624-8222 Fax: 405-372-3769 | |
Shanna Lynn Douglass, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 6th Ave Ste 207, Stillwater, OK 74074 Phone: 405-533-3010 | |
Sean Anderson, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 605 S Orchard St, Stillwater, OK 74074 Phone: 405-780-6650 Fax: 405-844-0562 |